These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17634471)

  • 1. Prophylaxis for thromboembolism in hospitalized medical patients.
    Calderón-Gerstein W
    N Engl J Med; 2007 Jul; 357(3):304-5; author reply 305-6. PubMed ID: 17634471
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients.
    Francis CW
    N Engl J Med; 2007 Apr; 356(14):1438-44. PubMed ID: 17409325
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of pulmonary embolism].
    Minar E
    Acta Med Austriaca; 1992; 19(1):25-34. PubMed ID: 1316706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summaries for patients: Preventing venous thromboembolism in hospitalized patients: recommendations from the American College of Physicians.
    Ann Intern Med; 2011 Nov; 155(9):I38. PubMed ID: 22041965
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
    Caprini JA
    Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
    [No Abstract]   [Full Text] [Related]  

  • 7. [Initial results of the PROTECT Study publicized. Stroke patients need effective thrombosis prevention].
    Diener HC
    MMW Fortschr Med; 2005 Jun; 147(22):50. PubMed ID: 15977636
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.
    Dentali F; Douketis JD; Gianni M; Lim W; Crowther MA
    Ann Intern Med; 2007 Feb; 146(4):278-88. PubMed ID: 17310052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronic alerts to prevent venous thromboembolism among hospitalized patients.
    Kucher N; Koo S; Quiroz R; Cooper JM; Paterno MD; Soukonnikov B; Goldhaber SZ
    N Engl J Med; 2005 Mar; 352(10):969-77. PubMed ID: 15758007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic alerts to prevent venous thromboembolism.
    White RH; Keenan CR; Kaboli CR
    N Engl J Med; 2005 Jun; 352(22):2349-50; author reply 2349-50. PubMed ID: 15934140
    [No Abstract]   [Full Text] [Related]  

  • 12. A need for a simplified approach to venous thromboembolism prophylaxis in acute medical inpatients.
    Howard DP
    Int J Clin Pract; 2007 Feb; 61(2):336-40. PubMed ID: 16889637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Venous thromboembolism prophylaxis].
    Dohmen B; Gogarten W; Kuhlen R; Rossaint R
    Anaesthesist; 2004 Jul; 53(7):657-72; quiz 673. PubMed ID: 15292966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of venous thromboembolism among hospitalized medical patients.
    Goldhaber SZ; Turpie AG
    Circulation; 2005 Jan; 111(1):e1-3. PubMed ID: 15630031
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.
    Samama MM; Cohen AT; Darmon JY; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Nguyen H; Olsson CG; Turpie AG; Weisslinger N
    N Engl J Med; 1999 Sep; 341(11):793-800. PubMed ID: 10477777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxaparin for the prevention of venous thromboembolism.
    Calderon EJ; Varela JM; Gonzalez de la Puente MA
    N Engl J Med; 2000 Jan; 342(2):136-7. PubMed ID: 10636758
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis.
    Bergqvist D
    J Surg Oncol; 2007 Feb; 95(2):167-74. PubMed ID: 17262765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.